Purpura, Thrombotic Thrombocytopenic - 25 Studies Found
Terminated |
: Safety and Efficacy Study to Compare Uniplas With Cryosupernatant Plasma in Thrombotic Thrombocytopenic Purpura (TTP) : Thrombotic Thrombocytopenic Purpura (TTP) : 2006-12-13 :
|
Completed |
: Phase 1 Dose Escalation, Single Dose Study to Assess Safety and Pharmacokinetics of BAX930 in Hereditary Thrombotic Thrombocytopenic Purpura (TTP) : Hereditary Thrombotic Thrombocytopenic Purpura (TTP) : 2014-08-12 : Drug: Recombinant ADAMTS13 rADAMTS13 (a disintegrin and me |
Recruiting |
: Low Dose Rituximab in Thrombotic Thrombocytopenic Purpura : Thrombotic Thrombocytopenic Purpura : 2012-03-08 : Biological: rituximab rituximab intravenously 100 mg every week for four doses |
Not yet recruiting |
: Octaplas Adult TTP Trial : Thrombotic Thrombocytopenic Purpura : 2013-09-02 :
|
Terminated |
: Evaluating the Effectiveness of Adding Rituximab to Standard Treatment for Thrombotic Thrombocytopenic Purpura (TTP) : Thrombotic Thrombocytopenic Purpura : 2008-11-26 :
|
Enrolling by invitation |
: A Pilot Study of N-acetylcysteine in Thrombotic Thrombocytopenia Purpura :
: 2013-02-22 : Drug: N-Acetylcysteine IV administration of N-Acetylcysteine at 150mg/kg over 60 min first, then if well |
Recruiting |
: Genotype and Phenotype Correlation in Hereditary Thrombotic Thrombocytopenic Purpura (Upshaw-Schulman Syndrome) :
|
Completed |
: ARC1779 Injection in Patients With Von Willebrand Factor-Related Platelet Function Disorders :
|
Completed |
: Rituximab in Patients With Relapsed or Refractory TTP-HUS :
|